MS

Md Shible Noomani

Active Director Director DIN 10786103
DIN 10786103 First appointment Sep 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Md Shible Noomani

Data last updated:

Md Shible Noomani is a Director at Cognasia Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10786103
Primary Designation Director
Industry Paper
First Appointment 24 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Sep 20242024Active

Board colleagues of Md Shible Noomani

NameDINCompanyDesignation
Bibi Darkhsan10786102Cognasia Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cognasia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Md Shible Noomani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Md Shible Noomani

Md Shible Noomani currently holds 1 directorship: Cognasia Pharmaceuticals Private Limited (Director, since 24 Sep 2024).

Md Shible Noomani was first appointed on 24 Sep 2024 as Director at Cognasia Pharmaceuticals Private Limited.

The current boards of Md Shible Noomani's companies include Bibi Darkhsan (Cognasia Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available